Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,526 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DNA-based drug interactions of cisplatin.
Crul M, van Waardenburg RC, Beijnen JH, Schellens JH. Crul M, et al. Among authors: beijnen jh. Cancer Treat Rev. 2002 Dec;28(6):291-303. doi: 10.1016/s0305-7372(02)00093-2. Cancer Treat Rev. 2002. PMID: 12470980 Review.
High-dose chemotherapy regimens for solid tumors.
van der Wall E, Beijnen JH, Rodenhuis S. van der Wall E, et al. Among authors: beijnen jh. Cancer Treat Rev. 1995 Mar;21(2):105-32. doi: 10.1016/0305-7372(95)90023-3. Cancer Treat Rev. 1995. PMID: 7758003 Review.
Limited sampling models for topotecan pharmacokinetics.
van Warmerdam LJ, Verweij J, Rosing H, Schellens JH, Maes RA, Beijnen JH. van Warmerdam LJ, et al. Among authors: beijnen jh. Ann Oncol. 1994 Mar;5(3):259-64. doi: 10.1093/oxfordjournals.annonc.a058804. Ann Oncol. 1994. PMID: 8186175 Free article.
Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase II clinical trials using a limited-sampling procedure.
van Warmerdam LJ, Creemers GJ, Rodenhuis S, Rosing H, de Boer-Dennert M, Schellens JH, ten Bokkel Huinink WW, Davies BE, Maes RA, Verweij J, Beijnen JH. van Warmerdam LJ, et al. Among authors: beijnen jh. Cancer Chemother Pharmacol. 1996;38(3):254-60. doi: 10.1007/s002800050479. Cancer Chemother Pharmacol. 1996. PMID: 8646800 Clinical Trial.
Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study.
Veldhuis GJ, Willemse PH, Beijnen JH, Boonstra H, Piersma H, van der Graaf WT, de Vries EG. Veldhuis GJ, et al. Among authors: beijnen jh. Br J Cancer. 1997;75(5):703-9. doi: 10.1038/bjc.1997.125. Br J Cancer. 1997. PMID: 9043028 Free PMC article. Clinical Trial.
1,526 results